StockData
Nutanix, Inc. logo

Nutanix, Inc. (NTNX) stock

NTNXNasdaqServices-Prepackaged SoftwareFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Sep 18, 2026Score 14/30100% below fair value
$56.52−2.42 (-4.11%)

Close on Nov 17, 2026Market cap $15.29BP/E –Yield –

Nutanix r&d expenses

Research and development expenses are spending on new products and technology.

Nutanix's R&D Expenses for the twelve months ending Jul 31, 2026 was $790.89M, up 7.3% year over year. For fiscal 2026 it was $790.89M, up 7.3% from the year before. Over ten years it grew 21.1% a year on average. The highest annual figure on record is $790.89M in fiscal 2026.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jul 31, 2026$790.89M+7.3%
FY2025Jul 31, 2025$736.82M+15.3%
FY2024Jul 31, 2024$638.99M+10.0%
FY2023Jul 31, 2023$580.96M+1.4%
FY2022Jul 31, 2022$573.00M+2.7%
FY2021Jul 31, 2021$558.01M+0.7%
FY2020Jul 31, 2020$553.98M+10.6%
FY2019Jul 31, 2019$500.72M+59.6%
FY2018Jul 31, 2018$313.78M+8.7%
FY2017Jul 31, 2017$288.62M+148.0%
FY2016Jul 31, 2016$116.40M+58.3%
FY2015Jul 31, 2015$73.51M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026$205.05M+5.9%
Q3 FY2026CQ1 2026Apr 30, 2026$196.10M+5.2%
Q2 FY2026CQ4 2025Jan 31, 2026$202.26M+10.7%
Q1 FY2026CQ3 2025Oct 31, 2025$187.48M+7.8%
Q4 FY2025CQ2 2025Jul 31, 2025$193.67M+15.7%
Q3 FY2025CQ1 2025Apr 30, 2025$186.41M+17.1%
Q2 FY2025CQ4 2024Jan 31, 2025$182.79M+14.0%
Q1 FY2025CQ3 2024Oct 31, 2024$173.96M+14.5%
Q4 FY2024CQ2 2024Jul 31, 2024$167.40M+14.5%
Q3 FY2024CQ1 2024Apr 30, 2024$159.22M+11.3%
Q2 FY2024CQ4 2023Jan 31, 2024$160.40M+12.7%
Q1 FY2024CQ3 2023Oct 31, 2023$151.98M+1.7%
Q4 FY2023CQ2 2023Jul 31, 2023$146.20M+1.3%
Q3 FY2023CQ1 2023Apr 30, 2023$143.02M+0.5%
Q2 FY2023CQ4 2022Jan 31, 2023$142.30M+0.3%
Q1 FY2023CQ3 2022Oct 31, 2022$149.44M+3.6%
Q4 FY2022CQ2 2022Jul 31, 2022$144.27M+1.8%
Q3 FY2022CQ1 2022Apr 30, 2022$142.33M-1.8%
Q2 FY2022CQ4 2021Jan 31, 2022$141.87M+4.6%
Q1 FY2022CQ3 2021Oct 31, 2021$144.27M+6.2%
Q4 FY2021CQ2 2021Jul 31, 2021$141.72M+4.7%
Q3 FY2021CQ1 2021Apr 30, 2021$144.92M+2.5%
Q2 FY2021CQ4 2020Jan 31, 2021$135.57M-2.5%
Q1 FY2021CQ3 2020Oct 31, 2020$135.80M-1.7%
Q4 FY2020CQ2 2020Jul 31, 2020$135.34M+4.8%
Q3 FY2020CQ1 2020Apr 30, 2020$141.35M+2.4%
Q2 FY2020CQ4 2019Jan 31, 2020$139.09M+13.0%
Q1 FY2020CQ3 2019Oct 31, 2019$138.21M+25.0%
Q4 FY2019CQ2 2019Jul 31, 2019$129.17M+33.1%
Q3 FY2019CQ1 2019Apr 30, 2019$137.98M+69.7%
Q2 FY2019CQ4 2018Jan 31, 2019$123.04M+73.5%
Q1 FY2019CQ3 2018Oct 31, 2018$110.53M+71.3%
Q4 FY2018CQ2 2018Jul 31, 2018$97.05M+43.1%
Q3 FY2018CQ1 2018Apr 30, 2018$81.29M+9.0%
Q2 FY2018CQ4 2017Jan 31, 2018$70.92M+0.0%
Q1 FY2018CQ3 2017Oct 31, 2017$64.51M-14.3%
Q4 FY2017CQ2 2017Jul 31, 2017$67.82M–
Q3 FY2017CQ1 2017Apr 30, 2017$74.61M–
Q2 FY2017CQ4 2016Jan 31, 2017$70.91M–
Q1 FY2017CQ3 2016Oct 31, 2016$75.28M–

More Nutanix figures

See a number that looks wrong?